Moleculin Biotech, Inc., a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, announced today Walter Klemp, Chairman and CEO, and Jonathan Foster, CFO, will present at the 10th Annual LD Micro Main Event on Tuesday, December 5, 2017.
